NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

脊髓損傷治療的全球市場 - 藥物的各類型、各用途、各給藥途徑、各流通管道、各地區:市場規模、佔有率、未來展望、機會分析

Spinal Cord Injury Therapeutics Market, by Injury Type, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 979992
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
脊髓損傷治療的全球市場 - 藥物的各類型、各用途、各給藥途徑、各流通管道、各地區:市場規模、佔有率、未來展望、機會分析 Spinal Cord Injury Therapeutics Market, by Injury Type, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月18日內容資訊: 英文 175 Pages
簡介

本報告提供全球脊髓損傷治療藥的市場相關分析,產品概要,及市場基本結構及促進、阻礙因素,整體市場規模預測 (以金額為準,過去4年、今後8年份),藥物的各類型、各用途、各給藥途徑、各流通管道、各地區的詳細趨勢,主要企業的簡介、業績、策略計劃等調查。

目錄

第1章 分析目的、前提條件

第2章 市場概要

  • 分析概要
  • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場力學、規定、趨勢分析

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 影響度分析
  • 近幾年主要的動向
  • 新產品的上市/認證
  • 企業合併、收購 (M&A) 方案
  • 開發平台分析
  • 流行病學
  • PEST分析
  • 醫療費償付

第4章 全球脊髓損傷治療藥市場:新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響

  • 為了應對COVID-19的各國政府的配合措施
  • COVID-19對醫療市場整體的影響
  • COVID-19對脊髓市場的影響

第5章 全球脊髓損傷治療藥市場:損傷的各類型

  • 簡介
  • 市場佔有率:損傷的各類型 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):損傷的各類型 (總計11年份)
  • 各市場區隔詳細趨勢
    • 脊髓完全損傷
    • 脊髓部分損傷

第6章 全球脊髓損傷治療藥市場:藥物的各類型

  • 簡介
  • 市場佔有率:藥物的各類型 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):藥物的各類型 (總計11年份)
  • 各市場區隔詳細趨勢
    • 皮質類固醇
    • 肌肉鬆弛劑、解痙藥
    • NSAID (非類固醇系抗發炎劑)
    • 抗憂鬱症藥
    • 抗痙攣藥
    • 其他

第7章 全球脊髓損傷治療藥市場:各用途

  • 簡介
  • 市場佔有率:各用途 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):各用途 (總計11年份)
  • 各市場區隔詳細趨勢
    • 植物性神經過反射 (AD)
    • 痙攣狀態、發炎
    • 疼痛管理

第8章 全球脊髓損傷治療藥市場:各給藥途徑

  • 簡介
  • 市場佔有率:各給藥途徑 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):各給藥途徑 (總計11年份)
  • 各市場區隔詳細趨勢
    • 口服
    • 靜脈注射

第9章 全球脊髓損傷治療藥市場:各流通管道

  • 簡介
  • 市場佔有率:各類型 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):各類型 (總計11年份)
  • 各市場區隔詳細趨勢
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第10章 全球脊髓損傷治療藥市場:各地區

  • 簡介
  • 市場佔有率分析:各國 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):各國 (總計11年份)
  • 北美
    • 簡介
    • 市場規模與其預測:損傷的各類型 (以金額為準,總計12年份)
    • 市場規模與其預測:藥物的各類型 (以金額為準,總計12年份)
    • 市場規模與其預測:各用途 (以金額為準,總計12年份)
    • 市場規模與其預測:各給藥途徑 (以金額為準,總計12年份)
    • 市場規模與其預測:各流通管道 (以金額為準,總計12年份)
    • 市場規模與其預測:各國 (以金額為準,總計12年份)
    • 美國
    • 加拿大
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美各國
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 東南亞國協
    • 其他的亞太地區各國
  • 中東
    • 波灣合作理事會 (GCC) 各國
    • 以色列
    • 其他的中東各國
  • 非洲
    • 非洲南部
    • 中部非洲
    • 北部非洲

第11章 競爭情形

  • 企業簡介
    • ReNetX Bio
    • InVivo Therapeutics Hldg
    • GTX Medical
    • Acorda Therapeutics
    • Lineage Cell Therapeutics
    • AbbVie Inc.
    • Asterias Biotherapeutics, Inc
    • BioArctic
    • Kringle Pharma, Inc.
    • Pfizer Inc.
    • Pharmicell Co., Ltd.
    • Bioaxone Biosciences, Inc.
    • Vertex Pharmaceuticals Inc.
    • Biogen Inc.
    • RespireRx Phamaceuticals Inc.
    • NervGen
    • Lannett Co Inc
    • Teva Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories
    • MSN Laboratories Private Limited
    • Rising Pharmaceuticals, Inc.
    • ScieGen Pharmaceuticals, Inc
    • Cadila Healthcare Limited
目錄

Title:
Spinal Cord Injury Therapeutics Market, by Injury Type (Complete Spinal Cord Injury and Incomplete Spinal Cord Injury), by Drug Type (Corticosteroids, Muscle Relaxants and Anti-spastic drugs, Non-steroidal Anti-inflammatory drugs ( NSAID'S), Anti-depressants, Anticonvulsants, and Others), by Application (Autonomic Dysreflexia (AD), Spasticity & Inflammation, Pain Management, and Depression), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

The global spinal cord injury therapeutics market comprises therapeutics used for the treatment of spinal cord injury. There are various therapeutics such as corticosteroids, non-steroidal anti-inflammatory drugs (NSAID'S), muscle relaxants and anti-depressants. There are two types of spinal cord injuries such as complete spinal cord injury and incomplete spinal cord injury and various causes of spinal cord injuries include brain injury, trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections.

Market Dynamics

Key players are focusing on product approvals to strengthen their position in the global spinal cord injury therapeutics market. For instance, in September 2020, AbbVie, received an orphan drug and fast track designation from the U.S. Food and Drug Administration for Elezanumab, an investigational monoclonal antibody RGMa inhibitor for the treatment of spinal cord injury.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global spinal cord injury therapeutics market. The market for spinal cord injury therapeutics is segmented on basis of injury type, drug type, application, route of administration, distribution channel, and region.
  • This report provides in-depth analysis of the global spinal cord injury therapeutics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global spinal cord injury therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global spinal cord injury therapeutics market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Detailed Segmentation:

  • Global Spinal Cord Injury Therapeutics Market, By Injury Type:
    • Complete Spinal Cord Injury
    • Incomplete Spinal Cord Injury
  • Global Spinal Cord Injury Therapeutics Market, By Drug Type:
    • Corticosteroids
    • Muscle Relaxants and Anti-spastic drugs
    • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
    • Anti-depressants
    • Anticonvulsants
    • Others
  • Global Spinal Cord Injury Therapeutics Market, By Application:
    • Autonomic Dysreflexia (AD)
    • Spasticity & Inflammation
    • Pain Management
    • Depression
  • Global Spinal Cord Injury Therapeutics Market, By Route of Administration :
    • Oral
    • Intravenous
  • Global Spinal Cord Injury Therapeutics Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Spinal Cord Injury Therapeutics Market, By Region:
    • North America
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Injury Type:
      • Complete Spinal Cord Injury
      • Incomplete Spinal Cord Injury
      • By Drug Type:
      • Corticosteroids
      • Muscle Relaxants and Anti-spastic drugs
      • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
      • Anti-depressants
      • Anticonvulsants
      • Others
      • By Application:
      • Autonomic Dysreflexia (AD)
      • Spasticity & Inflammation
      • Pain Management
      • Depression
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • ReNetX Bio.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • InVivo Therapeutics Hldg
    • GTX Medical
    • Acorda Therapeutics
    • Lineage Cell Therapeutics
    • AbbVie Inc.
    • Asterias Biotherapeutics, Inc
    • BioArctic
    • Kringle Pharma, Inc.
    • Pfizer Inc.
    • Pharmicell Co., Ltd.
    • Bioaxone Biosciences, Inc.
    • Vertex Pharmaceuticals Inc.
    • Biogen Inc.
    • RespireRx Phamaceuticals Inc.
    • NervGen
    • Lannett Co Inc
    • Teva Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories
    • MSN Laboratories Private Limited
    • Rising Pharmaceuticals, Inc.
    • ScieGen Pharmaceuticals, Inc
    • Cadila Healthcare Limited

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Injury Type
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Developments
  • New Product Launches/Approvals
  • Merger-Acquisition Scenario
  • Regulatory Scenario
  • Pipeline Analysis
  • Epidemiology
  • PEST Analysis
  • Reimbursement

4. Global Spinal Cord Injury Therapeutics Market - Impact of COVID-19 Pandemic

  • Government Initiative To Combat Covid-19
  • COVID 19 Impact on Overall Healthcare Market
  • COVID 19 Impact on Spinal Cord Market

5. Global Spinal Cord Injury Therapeutics Market, By Injury Type, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Complete Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Incomplete Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

6. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Muscle Relaxants and Anti-spastic drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Non-steroidal Anti-inflammatory drugs ( NSAID'S)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Anti-depressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Anticonvulsants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Autonomic Dysreflexia (AD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Spasticity & Inflammation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Injury Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Drug Type, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

11. Competitive Landscape

  • Company Profiles
    • ReNetX Bio
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • InVivo Therapeutics Hldg
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GTX Medical
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Acorda Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lineage Cell Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Asterias Biotherapeutics, Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BioArctic
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kringle Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pharmicell Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bioaxone Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Vertex Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biogen Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • RespireRx Phamaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • NervGen
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lannett Co Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MSN Laboratories Private Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rising Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ScieGen Pharmaceuticals, Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies